Ouabain exacerbates activation-induced cell death in human peripheral blood lymphocytes

Anais da Academia Brasileira de Ciencias

Volumn 77, Issue 2, 2005, Pages 281-292

  Esteves, Mabel B ^a   Marques Santos, Luis F ^a   Affonso Mittdieri, Ottília R ^a   Rumjanek, Vivian M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Apoptosis; Lymphocytes; Membrane depolarization; Ouabain; PHA

Indexed keywords

STROPHANTHUS GRATUS;

EID: 19844380236     PISSN: 00013765     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0001-37652005000200008     Document Type: Review

References (37)

1. ANNER BM, LACOTTE D, ANNER RM AND MOOSMAYER M. 1994. Interaction of hypothalamic Na,K-ATPase inhibitor with isolated human peripheral blood mononuclear cells. Biosci Rep 14: 231-242.
2. BORTNER CD AND CIDLOWSKi JA. 1996. Absence of volume regulatory mechanism contributes to the rapid activation of apoptosis in thymocytes. Am J Physiol 271: C950-C961.
3. BORTNER CD, HUGHES FM AND CIDLOWSKI JA. 1997. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 272: 32436-32442.
4. BORTNER CD, GOMEZ-ANGELATS M AND CIDLOWSKI JA. 2001. Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis. J Biol Chem 276: 4304-4314.
5. BRODIE C, TORDAI A, SALOGA J, DOMENICO J AND GELFAND EW. 1995. Ouabain induces inhibition of the progression phase in human T-cell proliferation. J Cell Physiol 165: 246-253.
6. BRUNNER T, KASIBHATLA S, PINKOSKI MJ, FRUTSCHI C, YOO NJ, ECHEVERRI F, MAHBOUBI A AND GREEN DR. 2000. Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 275: 9767-9772.
7. DALLAPORTA B, HIRSCH T, SUSIN SA, ZAMZAMI N, LAROCHETTE N, BRENNER C, MARZO I AND KROEMER G. 1998. Potassium leakage during the apoptotic degradation phase. J Immunol 160: 5605-5615.
8. DALLAPORTA B, MARCHETTI P, PABLO MA, MAISSE C, DUC H-T, MÉTIVOER D, ZAMZAMI N, GEUSKENS M AND KROEMER G. 1999. Plasma membrane potential in thymocytes apoptosis. J Immunol 162: 6534-6542.
9. DE ALBORAN IM, O'HAGAN RC, GARTNER F, MALYNN B, DAVIDSON L, RICKET R, RAJEWSKY K, DEPINHO RA AND ALT FW. 2001. Analysis of C-Myc function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
10. GENESTIER L, KASIBHATLA S, BRUNNER T AND GREEN DR. 1999. Transforming growth factor β1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc. J Exp Med 189: 231-239.
11. HUGHES FM, BORTNER CD, PURDY GD AND CIDLOWSKI JA. 1997. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272: 30567-30576.
12. JENSEN P, WINGER L AND NOWELL P. 1977. The mitogenic effect of A23187 in human peripheral lymphocytes. Biochim Biophys Acta 496: 374-383.
13. KASIBHATLA S, BEERE HM, BRUNNER T, ECHEVERRI F AND GREEN DR. 2000. A 'non-canonical' DNA-binding element mediates the response of the Fasligand promoter to c-Myc. Curr Biol 10: 1205-1208.
14. KAUFMANN SH AND HENGARTNER MO. 2001. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11: 526-534.
15. KIEFER H, BLUME AJ AND KABACK HR. 1980. Membrane potential changes during mitogenic stimulation of mouse spleen lymphocytes. Proc Natl Acad Sci USA 77: 2200-2204.
16. LATINIS KM, NORIAN LA, ELIASON SL AND KORETZKY GA. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 272: 31427-31434.
17. lck mediates activation of swelling-induced chloride channels in lymphocytes. J Cell Biol 141: 281-286.
18. LYNCH DH, RAMSDELL F AND ALDERSON MR. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569-574.
19. MAENO E, ISHIZAKI Y, KANASEKI T, HAZAMA A AND OKADA Y. 2000. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 97: 9487-9492.
20. +-adenosine triphosphatase. Endocrinology 142: 5059-5068.
21. MARTIN SJ AND GREEN DR. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82: 349-352.
22. MORAES VLG, OLEJ B, DE LA ROCQUE L AND RUMJANEK VM. 1989. Lack of sensitivity to ouabain in natural killer activity. FASEB J 3: 2425-2429.
23. NAGATA S AND GOLDSTEIN P. 1995. The Fas death factor. Science 267: 1449-1456.
24. NOBEL CSI, ARONSON JK, VAN DEN DOBBELSTEEN DJ AND SLATER AFG. 2000. Inhibition of Na+/K(+)-ATPase may be one mechanism contributing to potassium efflux and cell shrinkage in CD95-induced apoptosis. Apoptosis 5: 153-163.
25. OLEJ B, DE LA ROCQUE L, CASTILHO FPD, MEDIANO IF, CAMPOS MM AND RUMJANEK VM. 1994. Effect of ouabain on lymphokine-activated killer cells. Int J Immunopharmacol 16: 769-774.
26. OLEJ B, DOS SANTOS NF, LEAL L AND RUMJANEK VM. 1998. Ouabain induces apoptosis on PHA - activated lymphocytes. Bioscience Reports 18: 1-7.
27. + ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J Biol Chem 274: 16545-16552.
28. PERREGAUX D AND GABEL CA. 1994. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269: 15195-15203.
29. PIRES V, HARAB RC, OLEJ B AND RUMJANEK VM. 1997. Ouabain effects on activated lymphocytes: augmentation of CD2S expression on TPA-stimulated cells and of CD69 on PHA- and TPA-stimulated cells Int J Immunopharmac 19: 143-148.
30. QUASTEL MR AND KAPLAN JG. 1968. Inhibition by Ouabain of human lymphocyte transformation induced by phytohaemagglutinin in vitro. Nature 219: 198-200.
31. REDONDO JM, LOPEZ RIVAS A AND FRESNO M. 1986. Activation of the Na+/K+-ATPase by interleukin-2. FEBS Lett 206: 199-202.
32. +-pump. FEBS Lett 268: 314-324.
33. SZABÒ I, LEPPLE-WIENHUES A, KABA NK, ZORATTI M, GULBINS E AND LANG F. 1998. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc Natl Acad Sci USA 95: 6169-6174.
34. +)-ATPase and lysolecithin acyltransferase in plasma membranes of mitogen-stimulated rabbit thymocytes. J Biol Chem 256: 9198-9204.
35. SZAMEL M, LEUFGEN H, KURRLE R AND RESCH K. 1995. Differential signal transduction pathways regulating interleukin-2 synthesis and interleukin-2 receptor expression in stimulated human lymphocytes. Biochim Biophys Acta 1235: 33-42.
36. WALEV I, RESKE K, PALMER M, VALEVA A AND BHAKDI S. 1995. Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J 14: 1607-1614.
37. WANG R, BRUNNER T, ZHANG L AND SHI Y. 1998. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression. Oncogene 17: 1503-1508.